Gastroretentive dosage forms of levodopa and carbidopa
The present disclosure provides self-regulating, oral, permeable, floating gastric retentive CD/LD compositions suitable for one or two daily administration. The composition provides sustained release with enhanced LD pharmacokinetic properties, such as reduced lag time, avoidance of low ebb levels,...
Gespeichert in:
Hauptverfasser: | , , , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!